Find generic entry opportunities
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses|
|Abstract:||The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, ##STR00001## wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.|
|Inventor(s):||Differding; Edmond (Louvain-la-Neuve, BE), Kenda; Beno t (Emines, BE), Lallemand; Benedicte (Waimes, BE), Matagne; Alain (Gerpinnes, BE), Michel; Philippe (Beersel, BE), Pasau; Patrick (Chastre, BE), Talaga; Patrice (Watermael-Boitsfort, BE)|
|Assignee:||UOB Pharma, S.A. (Brussels, BE)|
|Filing Date:||Feb 17, 2010|
|Claims:||1. A method of preparation of compound of formula (I) ##STR00072## wherein X is --CA.sup.1NR.sup.5R.sup.6 or --CA.sup.1-R.sup.8; A.sup.1 is oxygen, sulfur or --NR.sup.9; R.sup.1 is hydrogen, alkyl, aryl or --CH.sub.2--R.sup.1a wherein R.sup.1a is aryl, halogen, hydroxy, amino, nitro or cyano; R.sup.3 is hydrogen, halogen, thiol, nitro, nitrooxy, cyano, azido, carboxy, amido, sulfonic acid, sulfonamide, alkyl, alkenyl, alkynyl, ester, ether, aryl, tetrazolyl, thiazolyl, thienyl, furyl, pyrrolyl, pyridinyl, alkynyloxy, acyloxy, oxyester, oxyamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy, aralkoxy, alkylthio, alkenylthio, alkynylthio, arylthio, formyl, acetyl, propionyl, isobutyryl, valeryl, lauroyl, heptanedioyl, cyclohexanecarbonyl, crotonoyl, furmaroyl, acyloyl, benzoyl, naphtoyl, 4-carboxybutanoyl, oxalyl, ethoxalyl, cysteinyl, oxamoyl, alkylsulfonyl, alkenylsulfonyl, alkynylsulfonyl, arylsulfonyl, alkylsulfinyl, alkenylsulfinyl, alkynylsulfinyl or arylsulfinyl; R.sup.3a is hydrogen, halogen, alkyl, alkenyl, alkynyl or aryl; R.sup.5, R.sup.6 and R.sup.9 are the same or different and each is independently hydrogen, hydroxy, alkyl, aryl, alkoxy, alkenyloxy, alkynyloxy, acyloxy, oxyester, oxyamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy or arylakoxy; and R.sup.8 is hydrogen, hydroxy, thiol, halogen, alkyl, aryl, alkylthio, alkenylthio, alkynylthio; with the provisos that at least one of R.sup.3 and R.sup.3a is other than hydrogen; and that when the compound is a mixture of all possible isomers, X is --CONR.sup.5R.sup.6 and R.sup.1 is hydrogen, methyl, ethyl or propyl then R.sup.3 and R.sup.3a substitution is other than mono-, di-methyl or mono-ethyl; and that when R.sup.1 and R.sup.3a are both hydrogen and X is --CONR.sup.5R.sup.6 then R.sup.3 is different from carboxy, ester, amido, substituted oxo-pyrrolidine, alkynyloxy, acyloxy, oxyester, oxyamido, alkylsulfonyloxy, alkylsulfinyloxy, arylsulfonyloxy, arylsulfinyloxy, aryloxy, aralkoxy, methyl, naphtyl, phenyl optionally substituted by oxy derivatives or in the para position by an halogen atom; which comprises cyclisation of a compound of formula (AA-II) ##STR00073## wherein R.sup.1, R.sup.3, R.sup.3a and X are as defined above for compound of formula (I) and Q.sup.1 together with the oxygen to which it is attached is a leaving group. |
2. The method of preparation of compound of formula (I) according to claim 1 wherein Q.sup.1 is a substituent group selected from, a) alkyl; or b) linear or branched C.sub.1-4-alkyl.
3. The method of preparation of compound of formula (I) according to claim 1 wherein R.sup.1 is alkyl; X is --CA.sup.1NR.sup.5R.sup.6; R.sup.3 is alkyl or alkenyl; and R.sup.3a is hydrogen.
4. A method of preparation of (2S)-2-[(4S)-2-oxo-4-propylpyrrolidinyl]butanamide 158 and (2S)-2-[(4R)-2-oxo-4-propylpyrrolidinyl]butanamide 159 which comprises reduction of compound 374: ##STR00074##
5. The method of preparation according to claim 4 which is performed in the presence of Pd/C in an aqueous solution of NH.sub.4COOH.
6. The method of preparation according to claim 4 which comprises separation of (2S)-2-[(4S)-2-oxo-4-propylpyrrolidinyl]butanamide 158 and (2S)-2-[(4R)-2-oxo-4-propylpyrrolidinyl]butanamide 159.
7. The method of preparation according to claim 4 which affords (2S)-2-[(4R)-2-oxo-4-propylpyrrolidinyl]butanamide 159.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.